by Ket Patel | Jun 21, 2024 | Latest News
The PDUFA date refers to the deadline set by the US Food and Drug Administration for reviewing drug applications. The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug...
by Ket Patel | Jun 20, 2024 | Latest News
Key takeaways: Semaglutide benefits were observed for adults with type 2 diabetes and chronic kidney disease whether or not they used SGLT2 inhibitors. The FLOW trial was not powered to observe effects for those on SGLT2s. ORLANDO — Semaglutide use was associated with...
by Ket Patel | May 21, 2024 | All Videos, Home video, Stroke
This interview discusses anticoagulant reversal strategies in ICH and the current challenges and latest insights. The interview was conducted during ESOC 2024 at the ESOC studios, featuring Professor Thorsten Steiner & Dr David Seiffge This discussion is...
by Ket Patel | May 21, 2024 | All Videos, Home video, Stroke
This series of interviews provides the latest updates on SESAME, SOFIA EPI, and ERIC for distal, moderated by Professor Jens Fiehler. Interview 1 – SESAME – Controlled trial Latest results – Prof. Markus Mohlenbruch Interview 2 – SOFIA EPI – Real life data...
by Ket Patel | Apr 2, 2024 | Latest News
Key takeaways: Dapagliflozin did not improve diuretic efficiency for patients hospitalized with acute HF. It did, however, require fewer diuretic doses, fewer daily uptitrations and shorter hospital stay vs. usual care. Despite dapagliflozin not improving diuretic...
